Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Mylanta Gas Minis Mint Flavor

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2016
Label revision date
December 4, 2023
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2016
Label revision date
December 4, 2023
Manufacturer
Infirst Healthcare Inc.
Registration number
M002
NDC root
62372-800
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (2 NDCs)
Packaging & NDC Codes (2)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Mylanta Gas Minis are chewable mini-tablets designed to provide fast relief from the pressure and bloating commonly associated with gas. They are known for their effectiveness as one of the top-selling medicines for gas relief, offering a convenient on-the-go option in great-tasting flavors like Assorted Fruit and Cherry.

These extra-strength tablets help alleviate discomfort caused by gas, making them a helpful choice for those seeking quick relief from bloating and pressure.

Uses

If you're experiencing discomfort from gas, this medication can help relieve the pressure and bloating that often accompany it. It's designed to provide fast relief from the uncomfortable sensations of gas, making it a popular choice for many.

With its Extra Strength formula, this medicine is the #1 selling option for gas relief, ensuring you can get back to feeling your best quickly.

Dosage and Administration

If you are an adult or a child aged 12 years and older, you can take this medication by thoroughly chewing 3 to 6 mini-tablets whenever you need it. It's important to remember that you should not take more than 12 mini-tablets in a 24-hour period unless your doctor has specifically advised you to do so. Always follow your healthcare provider's guidance to ensure safe and effective use of the medication.

What to Avoid

You can feel confident using this medication, as there are no specific contraindications (conditions that would prevent you from taking it) or concerns about abuse, misuse, or dependence (a condition where your body becomes reliant on a substance). Additionally, there are no particular instructions indicating that you should avoid taking or using this medication under any circumstances. Always remember to follow your healthcare provider's guidance for the best results.

Side Effects

It's important to keep this medication out of the reach of children to prevent accidental ingestion. If you have any concerns about side effects or how to use this medication safely, please consult your healthcare provider for guidance.

Warnings and Precautions

It’s important to keep this medication out of the reach of children to prevent accidental ingestion, which can be dangerous. Always store it in a safe place where children cannot access it.

If you experience any unusual symptoms or side effects, stop using the medication and call your doctor immediately. Your health and safety are the top priority, so don’t hesitate to seek help if you have concerns.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there are no specific signs or symptoms of overdose mentioned, you should be aware that common signs can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms or feel concerned, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get professional assistance if you think you or someone else may have taken too much of a medication. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no specific information available about the use of Mylanta Gas Minis (which contains simethicone) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been established.

Before using this product, it’s a good idea to consult with your healthcare provider to discuss any potential risks and to ensure that it is safe for you and your baby. Always prioritize open communication with your doctor regarding any medications you consider taking during pregnancy.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to be aware that there is no specific information available regarding the use of this medication during nursing. This means that the effects on breast milk and your baby are not clearly defined.

As a precaution, you may want to discuss any medications you are considering with your healthcare provider to ensure they are safe for you and your nursing infant. Always prioritize open communication with your doctor about your breastfeeding status when making decisions about your health.

Pediatric Use

It's important to keep this medication out of the reach of children to ensure their safety. For adults and children aged 12 years and older, the recommended dosage is to thoroughly chew 3 to 6 mini-tablets as needed. However, you should not exceed 12 mini-tablets in a 24-hour period unless directed by a doctor. Always consult with a healthcare professional if you have any questions or concerns about using this medication for yourself or your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

It appears that there is no specific information regarding renal impairment (kidney problems) in the provided text. Therefore, there are no guidelines, dosage adjustments, or monitoring instructions to share for patients with kidney issues. If you have concerns about how your kidney health may affect your medication or treatment, it's important to discuss this with your healthcare provider for personalized advice and support.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, and there are no special monitoring or precautions outlined for patients like you.

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can provide guidance based on your individual situation.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that the medication is generally considered safe to use alongside other treatments or tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you. Always feel free to ask questions or express any concerns you may have regarding your medications or tests.

Storage and Handling

To ensure the best performance of your product, it's important to store it in a cool, dry place. Keep it protected from heat and moisture, as these can affect its quality. The ideal storage temperature is between 20-25°C (68-77°F).

When handling the product, make sure to do so with clean hands and in a clean environment to maintain its integrity. Following these guidelines will help ensure that the product remains safe and effective for your use.

Additional Information

For adults and children aged 12 years and older, you should thoroughly chew 3 to 6 mini-tablets as needed. It's important not to exceed 12 mini-tablets in a 24-hour period unless directed by a physician. Always follow your healthcare provider's advice regarding the use of this medication.

FAQ

What is Mylanta Gas Minis used for?

Mylanta Gas Minis relieves pressure and bloating commonly referred to as gas, providing fast relief from discomfort.

How should I take Mylanta Gas Minis?

Adults and children 12 years and older should thoroughly chew 3-6 mini-tablets as needed, but do not exceed 12 mini-tablets in 24 hours unless advised by a physician.

Are there any contraindications for Mylanta Gas Minis?

No specific contraindications are listed for Mylanta Gas Minis in the provided information.

Is Mylanta Gas Minis safe to use during pregnancy?

The provided information does not mention any specific safety concerns or dosage modifications for use during pregnancy.

What should I do if the breakaway band on the container is broken or missing?

Do not use Mylanta Gas Mini-tablets if the breakaway band on the top of the container is broken or missing.

How should I store Mylanta Gas Minis?

Store Mylanta Gas Minis at 20-25° C (68-77° F) and protect it from heat and moisture.

What flavors are available for Mylanta Gas Minis?

Mylanta Gas Minis are available in great tasting Assorted Fruit and Cherry flavors.

What should I do if I have children at home?

Keep Mylanta Gas Minis out of the reach of children to ensure their safety.

Packaging Info

Below are the non-prescription pack sizes of Mylanta Gas Minis Mint Flavor (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mylanta Gas Minis Mint Flavor.
Details

Drug Information (PDF)

This file contains official product information for Mylanta Gas Minis Mint Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Mylanta Gas Minis are chewable mini-tablets formulated for the fast relief of bloating, pressure, and discomfort associated with gas. Each package contains 50 tablets in a mint flavor, designed for convenience and portability. This extra strength formulation is recognized as the #1 selling medicine for gas relief. Mylanta Gas Minis are also available in assorted fruit and cherry flavors. The product is manufactured for Infirst Healthcare Inc., located in Westport, CT. It is important to note that the product is tamper evident; users should not utilize the tablets if the breakaway band on the top of the container is broken or missing. Mylanta is a registered trademark of McNeil Consumer Pharmaceuticals Co., and the product is protected by a pending patent. For complete labeling, consumers are advised to retain the outer packaging.

Uses and Indications

This drug is indicated for the relief of pressure and bloating commonly associated with gas. It provides fast relief from the discomfort, pressure, and bloating caused by gas. This formulation is classified as Extra Strength and is recognized as the #1 selling medicine for gas relief.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years and older are instructed to thoroughly chew 3 to 6 mini-tablets as needed. The maximum recommended dosage should not exceed 12 mini-tablets within a 24-hour period, unless otherwise directed by a physician. It is essential that patients adhere to this guideline to ensure safe and effective use of the medication.

Contraindications

There are no contraindications listed for this product. It is important to evaluate individual patient circumstances and consult relevant clinical guidelines when considering its use.

Warnings and Precautions

It is imperative to keep this medication out of the reach of children to prevent accidental ingestion or misuse.

Healthcare professionals are advised to educate patients and caregivers about the importance of secure storage practices to mitigate the risk of pediatric exposure. Regular reminders regarding the safe handling and storage of medications should be emphasized during consultations.

Side Effects

Patients should be advised to keep this medication out of the reach of children. This warning is critical to prevent accidental ingestion or exposure, which could lead to serious adverse reactions.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond this warning. It is essential for healthcare providers to monitor patients for any unexpected effects and to educate them on the importance of proper storage and handling of the medication.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Mylanta Gas Minis Mint Flavor (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mylanta Gas Minis Mint Flavor.
Details

Pediatric Use

Pediatric patients should be kept out of the reach of children. For adolescents aged 12 years and older, the recommended dosage is to thoroughly chew 3-6 mini-tablets as needed. It is important not to exceed 12 mini-tablets in a 24-hour period unless advised and supervised by a physician.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

There is no specific information regarding the use of Mylanta Gas Minis (simethicone) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pregnant patients, as the absence of data does not rule out potential risks. It is advisable to weigh the benefits against any unknown risks when prescribing this medication to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols. The implementation of these measures is crucial to ensure patient safety and effective management of overdose situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young individuals. Providers should emphasize the necessity of storing the medication in a secure location, away from children's sight and reach, to ensure safety.

Storage and Handling

The product is supplied in packaging that ensures its integrity and efficacy. It must be stored in a controlled environment, specifically at temperatures ranging from 20 to 25° C (68 to 77° F).

To maintain the quality of the product, it is essential to protect it from heat and moisture. Proper storage conditions are critical to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

Patients aged 12 years and older are advised to thoroughly chew 3-6 mini-tablets as needed, with a maximum limit of 12 mini-tablets within a 24-hour period unless directed otherwise by a physician. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mylanta Gas Minis Mint Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Mylanta Gas Minis Mint Flavor, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.